| Literature DB >> 33383654 |
Antonina Klimenko1,2, Robin Huber3,4, Laurence Marcourt3,4, Estelle Chardonnens1,3,4, Alexey Koval1, Yuri S Khotimchenko2, Emerson Ferreira Queiroz3,4, Jean-Luc Wolfender3,4, Vladimir L Katanaev1,2.
Abstract
Triple-negative breast cancer (TNBC) represents the deadliest form of gynecological tumors currently lacking targeted therapies. The ethanol extract of the North Pacific brittle star Ophiura sarsii presented promising anti-TNBC activities. After elimination of the inert material, the active extract was submitted to a bioguided isolation approach using high-resolution semipreparative HPLC-UV, resulting in one-step isolation of an unusual porphyrin derivative possessing strong cytotoxic activity. HRMS and 2D NMR resulted in the structure elucidation of the compound as (3S,4S)-14-Ethyl-9-(hydroxymethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid. Never identified before in Ophiuroidea, porphyrins have found broad applications as photosensitizers in the anticancer photodynamic therapy. The simple isolation of a cytotoxic porphyrin from an abundant brittle star species we describe here may pave the way for novel natural-based developments of targeted anti-cancer therapies.Entities:
Keywords: Ophiura sarsii; breast cancer; cytotoxicity; photodynamic therapy; porphyrin; targeted therapy
Mesh:
Substances:
Year: 2020 PMID: 33383654 PMCID: PMC7824513 DOI: 10.3390/md19010011
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118